HIGHLIGHTS
- who: Massimo Breccia from the AORMN Hospital, Italy Department of Translational and Precision Medicine, AzPoliclinico Umberto, Sapienza University have published the Article: Editorial: Risk-stratification in myelodysplastic syndromes, in the Journal: (JOURNAL)
- what: The studies presented in this Research Topic highlight the importance of prognostic tools for MDS which include somatic mutations as well as other clinical and laboratory parameters that help dissecting the heterogeneity of this group of diseases, allowing optimizing therapeutic strategies. was associated to a worse overall survival (OS) but not with progression-free survival (PFS).
- how: The authors declare . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.